285 related articles for article (PubMed ID: 15774502)
1. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside.
Li J; Bai Y; Ghandour K; Qin P; Grandis M; Trostinskaia A; Ianakova E; Wu X; Schenone A; Vallat JM; Kupsky WJ; Hatfield J; Shy ME
Brain; 2005 May; 128(Pt 5):1168-77. PubMed ID: 15774502
[TBL] [Abstract][Full Text] [Related]
2. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
[TBL] [Abstract][Full Text] [Related]
3. PMP22 expression in dermal nerve myelin from patients with CMT1A.
Katona I; Wu X; Feely SM; Sottile S; Siskind CE; Miller LJ; Shy ME; Li J
Brain; 2009 Jul; 132(Pt 7):1734-40. PubMed ID: 19447823
[TBL] [Abstract][Full Text] [Related]
4. [Detection of duplications or deletions of the PMP22 gene using real-time quantitative PCR].
Zhang FF; Tang BS; Shen Y; Zhao GH; Xia K; Zhao YQ; Chen B; Zhang C; Pan Q; Cai F; Liu XM; Luo W; Zhang RX; Guo P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):537-40. PubMed ID: 16215943
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural immunocytochemical abnormalities of peripheral myelin proteins in hereditary sensory-motor neuropathies: 12 cases.
Anani T; Sindou P; Richard L; Diot M; Vallat JM
Ann N Y Acad Sci; 1999 Sep; 883():186-95. PubMed ID: 10586244
[TBL] [Abstract][Full Text] [Related]
6. Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A.
Kobsar I; Hasenpusch-Theil K; Wessig C; Müller HW; Martini R
J Neurosci Res; 2005 Sep; 81(6):857-64. PubMed ID: 16041800
[TBL] [Abstract][Full Text] [Related]
7. [Molecular genetics of inherited neuropathies].
Takashima H
Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
[TBL] [Abstract][Full Text] [Related]
8. [Molecular pathology of Charcot-Marie-Tooth disease type 1A: abnormal expression of PMP-22].
Yoshikawa H; Nishimura T; Yanagihara T
Rinsho Shinkeigaku; 1995 Dec; 35(12):1441-3. PubMed ID: 8752424
[TBL] [Abstract][Full Text] [Related]
9. Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A.
Saporta MA; Katona I; Lewis RA; Masse S; Shy ME; Li J
Brain; 2009 Dec; 132(Pt 12):3263-73. PubMed ID: 19923170
[TBL] [Abstract][Full Text] [Related]
10. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
Naef R; Suter U
Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
[TBL] [Abstract][Full Text] [Related]
11. Expression pattern of the peripheral myelin protein 22kDa (PMP22) in neural and non-neural tissue types of adult wildtype and Trembler mice--a comparative study.
Rautenstrauss B; Zechner U; Hameister H; Grehl H; Liehr T
J Peripher Nerv Syst; 1998; 3(2):117-24. PubMed ID: 10959245
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory demyelination in a patient with CMT1A.
Vital A; Vital C; Lagueny A; Ferrer X; Ribière-Bachelier C; Latour P; Petry KG
Muscle Nerve; 2003 Sep; 28(3):373-6. PubMed ID: 12929199
[TBL] [Abstract][Full Text] [Related]
13. A novel mutation, Thr65Ala, in the MPZ gene in a patient with Charcot-Marie-Tooth type 1B disease with focally folded myelin.
Kochanski A; Drac H; Kabzińska D; Hausmanowa-Petrusewicz I
Neuromuscul Disord; 2004 Mar; 14(3):229-32. PubMed ID: 15036333
[TBL] [Abstract][Full Text] [Related]
14. Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies.
Li J; Ghandour K; Radovanovic D; Shy RR; Krajewski KM; Shy ME; Nicholson GA
Arch Neurol; 2007 Jul; 64(7):974-8. PubMed ID: 17620487
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).
Sereda MW; Meyer zu Hörste G; Suter U; Uzma N; Nave KA
Nat Med; 2003 Dec; 9(12):1533-7. PubMed ID: 14608378
[TBL] [Abstract][Full Text] [Related]
16. Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies.
Gabriel JM; Erne B; Pareyson D; Sghirlanzoni A; Taroni F; Steck AJ
Neurology; 1997 Dec; 49(6):1635-40. PubMed ID: 9409359
[TBL] [Abstract][Full Text] [Related]
17. Hemizygous mutation of the peripheral myelin protein 22 gene associated with Charcot-Marie-Tooth disease type 1.
Numakura C; Lin C; Oka N; Akiguchi I; Hayasaka K
Ann Neurol; 2000 Jan; 47(1):101-3. PubMed ID: 10632107
[TBL] [Abstract][Full Text] [Related]
18. Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy.
Meyer zu Horste G; Prukop T; Liebetanz D; Mobius W; Nave KA; Sereda MW
Ann Neurol; 2007 Jan; 61(1):61-72. PubMed ID: 17262851
[TBL] [Abstract][Full Text] [Related]
19. The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22.
Niemann S; Sereda MW; Rossner M; Stewart H; Suter U; Meinck HM; Griffiths IR; Nave KA
Ann N Y Acad Sci; 1999 Sep; 883():254-61. PubMed ID: 10586250
[TBL] [Abstract][Full Text] [Related]
20. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]